Profil
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd. Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Aktiva positioner av Racheli Ofir
| Företag | Position | Start |
|---|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Verkställande Direktör | 2022-12-01 |
Tidigare kända positioner av Racheli Ofir
| Företag | Position | Slut |
|---|---|---|
| PLURI INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-05-01 |
Racheli Ofirs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Institute of Technology
Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Technology Services |
















